Amyloid-Targeting Monoclonal Antibodies for Alzheimer Disease

JAMA. 2023 Aug 8;330(6):507-509. doi: 10.1001/jama.2023.11703.

Authors

Gil D Rabinovici^{1

2}, Renaud La Joie¹

Affiliations

¹ Memory & Aging Center, Department of Neurology, University of California San Francisco.
² Department of Radiology & Biomedical Imaging, University of California San Francisco.

PMID: 37459124
DOI: 10.1001/jama.2023.11703

No abstract available

Publication types

Editorial
Comment

MeSH terms

Alzheimer Disease* / therapy
Amyloid / immunology
Amyloid beta-Peptides
Antibodies, Monoclonal / immunology
Antibodies, Monoclonal / therapeutic use
Humans

Substances

Antibodies, Monoclonal
Amyloid beta-Peptides
Amyloid